iCAD Shares Climb After 4Q Sales Guidance Beats Expectations

Dow Jones

Jan 28, 2025

By Owen Tucker-Smith

iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations.

Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months.

The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million.

The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers.

iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February.

Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com

(END) Dow Jones Newswires

January 27, 2025 14:12 ET (19:12 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2506586089"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2506586089\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2506586089?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-28 03:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2506586089","market":"us","top_or_hot":-1,"title":"iCAD Shares Climb After 4Q Sales Guidance Beats Expectations","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Owen Tucker-Smith \n</p>\n<pre>\n \n</pre>\n<p>\n  iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations. \n</p>\n<p>\n  Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months. \n</p>\n<p>\n  The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million. \n</p>\n<p>\n  The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers. \n</p>\n<p>\n  iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 27, 2025 14:12 ET (19:12 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>iCAD Shares Climb After 4Q Sales Guidance Beats Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\niCAD Shares Climb After 4Q Sales Guidance Beats Expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-28 03:12</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Owen Tucker-Smith \n</p>\n<pre>\n \n</pre>\n<p>\n  iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations. \n</p>\n<p>\n  Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months. \n</p>\n<p>\n  The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million. \n</p>\n<p>\n  The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers. \n</p>\n<p>\n  iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 27, 2025 14:12 ET (19:12 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ICAD","symbol_name":"icad inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2506586089","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2506586089","pubTimestamp":1738005120,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations.Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months.The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million.The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers.iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ICAD":"icad inc."},"translate_title":"第四季度销售指引超出预期后iCAD股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICAD":0.9},"content_text":"By Owen Tucker-Smith \n\n\n \n\n\n  iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations. \n\n\n  Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months. \n\n\n  The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million. \n\n\n  The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers. \n\n\n  iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February. \n\n\n \n\n\n  Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 27, 2025 14:12 ET (19:12 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}